Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

TRAVERE THERAPEUTICS

Filed by 2359 STRATEGIES.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-15 06:26:11 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 19, 2025
Income
$12,000.00
Expenses
Not reported
Registrant
2359 STRATEGIES
Filing UUID
87c0a666-f6b5-4ae7-bdf7-6cbd7c276b74
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Literal federal measure citations: H.R.1518

HCR · Health Issues

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Literal federal measure citations: H.R.1518

MED · Medical/Disease Research/Clinical Labs

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Literal federal measure citations: H.R.1518

PHA · Pharmacy

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Literal federal measure citations: H.R.1518

TAX · Taxation/Internal Revenue Code

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Literal federal measure citations: H.R.1518

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.